Feng Guo
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Co-authors
- Zhihua Lu (7 shared papers)Yi Miao (19 shared papers)Jishu Wei (18 shared papers)Yongjun Lin (4 shared papers)Kuirong Jiang (18 shared papers)Wentao Gao (15 shared papers)Zipeng Lu (16 shared papers)Ying Ding (3 shared papers)
- Journals
- Pancreatology (5 papers)International Journal of Molecular Medicine (3 papers)Cancer Immunology Immunotherapy (2 papers)Critical Care (2 papers)JAMA Network Open (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Feng Guo
63 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 87
- Cancer Research 165
- Critical Care and Intensive Care Medicine 48
- Oncology 249
- Molecular Medicine 42
- Surgery 310
Countries citing papers authored by Feng Guo
This map shows the geographic impact of Feng Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Guo more than expected).
Fields of papers citing papers by Feng Guo
This network shows the impact of papers produced by Feng Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Guo. The network helps show where Feng Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 91 | |
| 2 | 2022 | 89 | |
| 3 | 2017 | 60 | |
| 4 | 2016 | 45 | |
| 5 | 2021 | 44 | |
| 6 | 2023 | 43 | |
| 7 | 2012 | 43 | |
| 8 | 2019 | 39 | |
| 9 | 2023 | 36 | |
| 10 | 2022 | 34 | |
| 11 | 2019 | 31 | |
| 12 | 2013 | 28 | |
| 13 | 2019 | 28 | |
| 14 | 2016 | 27 | |
| 15 | 2017 | 26 | |
| 16 | 2020 | 25 | |
| 17 | 2019 | 24 | |
| 18 | 2021 | 24 | |
| 19 | 2016 | 24 | |
| 20 | 2018 | 22 |
About Feng Guo
Feng Guo is a scholar working on Oncology, Surgery, Cancer Research, Pathology and Forensic Medicine and Molecular Medicine, having authored 68 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (17 papers), Pancreatitis Pathology and Treatment (15 papers), Clinical Nutrition and Gastroenterology (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Antibiotic Resistance in Bacteria (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (165 citations), Critical Care and Intensive Care Medicine (48 citations), Oncology (249 citations), Molecular Medicine (42 citations) and Surgery (310 citations). Feng Guo has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Zhihua Lu, Yi Miao, Jishu Wei, Yongjun Lin, Kuirong Jiang, Wentao Gao, Zipeng Lu, Ying Ding, Qiuping Xu and Junli Wu. Their work appears in journals such as Pancreatology, International Journal of Molecular Medicine, Cancer Immunology Immunotherapy, Critical Care and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.